MicroCME: JAK Inhibitors in Atopic Dermatitis

Price: FREE to members; $20 non-members

Length: 11 minutes

This microlearning, presented by Dr. Andrew Alexis, discusses the use of JAK inhibitors in atopic dermatitis.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Practicing allergists
Allied health professionals
Primary Care Providers
Fellows-in-Training

Learning Objectives

By participating in this course, learners should be able to:

  • Improve knowledge regarding JAK inhibitors for AD.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Examples of such organizations include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
Course opens: 
04/01/2024
Course expires: 
12/31/2025
Cost:
$20.00
Rating: 
0

Mary Beth Hudelson, MD, FACAAI, planner/reviewer 
Joel Klein, MD, FACAAI, planner
Tammy Peng, MD, planner
Desha Jordan, MD, planner
Karen Anstey, MD, planner
Evelyn Lomasney, MD, planner
Deepa Patadia, MD, planner 
Brianne Nicole Navetta-Modrov, MD, planner
Farrah Khan, MD, planner

Available Credit

  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance

Price

Cost:
$20.00
Please login or create an account to take this course.